Revenue: Revenue for the three months ended September 30, 2024, increased to approximately $1,958,000 compared to $397,000 ...

Creatinine is measured via a smartphone-based imaging system, while albumin levels are assessed with an indigenously ...

In a recent study published in Nature Communications, scientists at the Department of Microbiology, Tumor and Cell Biology at ...

In a recent study published in Nature Communications, scientists at the Department of Microbiology, Tumor and Cell Biology at ...

Varanasi, developed a new tool to detect kidney disease. The team created a paper microchip device. The device is cheap and ...

IL-18 has significant importance for cancer immune-oncology and combination with IL-12 on Sonnet’s FHAB platform which Sonnet believes could present an important oncology possibility The lock-and-load ...

CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced ...

NM32 is a first-in-class half-life-enhanced T-cell engager targeting ROR1, a tumor associated antigen with broad expression in solid tumors and hematological ...

NM32 is a first-in-class half-life-enhanced T-cell engager targeting ROR1, a tumor associated antigen with broad expression in solid tumors and hematological malignancies Low molecular weight of NM32 ...

Albumin industry is projected to witness a CAGR of 6.5% during the period 2024-2032. This growth can be attributed to ...

Investigators evaluated the molecular mechanisms underlying felzartamab's potential efficacy in IgAN. The findings will be presented at ASN Kidney Week 2024 October 23– 27. It is hypothesized ...